Showing results (751-760 of 825) with videos related to

Sort By:
Pageof 83
Scientific Reports|December 20, 2016
KIF2A regulates the spindle assembly and the metaphase I-anaphase I transition in mouse oocyteMing-Huang Chen, Yu Liu, Ya-Long Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 20, 2015
MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitroKun-Chun Chiang, Chi-Chin Sun, Ming-Huang Chen, et al.
Diabetology & Metabolic Syndrome|October 4, 2025
Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patientsMing-Hsun Lin, Ren-Hua Ye, Hong-Jie Jhou, et al.
Biomedicines|August 27, 2021
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 PathwayShin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, et al.
Cancer|July 20, 2012
Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinomaMing-Huang Chen, Kun-Ju Lin, Wu-Lung R Yang, et al.
Oncology|June 23, 2012
Evaluation of prognosis for carcinoma of unknown origin in elderly patientsHsueh-Ju Lu, Kuo-Wei Chen, Cheng-Hwai Tzeng, et al.
British Journal of Cancer|July 2, 2026
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trialChia-Jui Yen, Ming-Huang Chen, Yen-Yang Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 25, 2019
Highly Efficient and Stable White Light-Emitting Diodes Using Perovskite Quantum Dot PaperChieh-Yu Kang, Chun-Ho Lin, Chih-Hao Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma PatientsMing-Huang Chen, Jing-Jie Weng, Chi-Tung Cheng, et al.
Hepatology (Baltimore, Md.)|March 21, 2025
Associations between metabolic syndrome and cholangiocarcinoma risk: A large-scale population-based cohort studyTzu-I Chen, Ming-Huang Chen, Szu-Ching Yin, et al.
Pageof 83